Loading clinical trials...
Loading clinical trials...
A Comparative Bioavailability Study to Compare the Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of Fluticasone Propionate and Salmeterol Delivered by Fluticasone Propionate/ Salmeterol Combination in a Capsule-based Inhaler and a Multi-dose Dry Powder Inhaler, in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.
Conditions
Interventions
SERETIDE Rotacaps
SERETIDE Diskus
Locations
2
Australia
GSK Investigational Site
Randwick, New South Wales, Australia
GSK Investigational Site
Wellington, New Zealand
Start Date
October 25, 2010
Primary Completion Date
June 8, 2011
Completion Date
June 8, 2011
Last Updated
February 26, 2019
NCT07219173
NCT07486401
NCT02327897
NCT04706988
NCT04639791
NCT06471257
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions